Tick-Borne Diseases Raise New Economic Threat for U.S. Cattle Producers
A growing tick threat is exposing U.S. cattle herds to two nearly identical diseases that can trigger major economic losses.
U.S. cattle producers are facing a growing animal health challenge in 2026 as anaplasmosis and bovine theileriosis increasingly appear in the same herds, creating diagnostic confusion and potentially significant economic losses. Veterinarians and researchers are warning that the expansion of the invasive Asian longhorned tick and the continued spread of traditional tick vectors are exposing producers to diseases that often present identical symptoms but require very different management strategies. The issue matters because delayed diagnosis can increase mortality, reduce milk production, trigger reproductive losses and raise treatment costs across the beef and dairy sectors.
For decades, anaplasmosis was considered the primary tick-borne threat in the South and Midwest. However, bovine theileriosis caused by Theileria orientalis Ikeda has emerged as a serious new concern since its first identification in a Virginia cow-calf herd in 2017. Since then, the Asian longhorned tick has been confirmed in more than 25 states, raising fears that the disease could become endemic in additional production regions. Veterinarians report an increasing number of cases in which cattle display classic symptoms of anaplasmosis but either test negative or are infected with both pathogens simultaneously.
Both diseases attack red blood cells and produce nearly identical clinical signs, including fever, lethargy, anemia, pale mucous membranes, reduced feed intake, lower milk production and weight loss. They can also cause abortions in pregnant cows and leave recovered animals as lifelong carriers. This similarity creates a major challenge for producers because visual diagnosis in the chute is often impossible.
Experts stress that PCR testing is currently the only reliable way to distinguish between the two diseases. Diagnostic laboratories are increasingly using duplex PCR tests capable of detecting both pathogens simultaneously. Veterinarians emphasize that cattle showing signs of anaplasmosis but failing to respond to tetracycline treatment should immediately be evaluated for theileriosis.
The economic implications are becoming increasingly significant. Anaplasmosis can cause mortality rates of up to 50% in clinically affected adult cattle, while theileriosis generally causes lower mortality but can still produce severe losses in naïve herds. In addition to direct animal losses, producers may face increased veterinary expenses, reduced reproductive efficiency and lower overall herd productivity.
Theileriosis presents a particularly troubling scenario because there is currently no approved treatment available in the United States. While anaplasmosis can be managed through oxytetracycline treatments and chlortetracycline control programs, theileriosis relies almost entirely on supportive care and aggressive tick management. A veterinary-prescription vaccine is expected to become available later this year, although its effectiveness under field conditions remains uncertain.
Veterinarians note that both diseases tend to cause the greatest losses when they first enter previously unexposed herds. Over time, endemic herds may experience fewer severe clinical cases as some level of population immunity develops. Nevertheless, every newborn calf remains susceptible, ensuring that disease pressure can continue for years.
The expansion of the Asian longhorned tick is particularly concerning because it is creating entirely new risk areas for cattle producers. As tick populations spread into additional states, experts believe that routine surveillance, veterinarian consultation and strategic testing will become increasingly important components of herd health programs.
For many producers, the challenge is no longer whether tick-borne diseases will appear, but rather determining which disease is present and how quickly an effective response can be implemented. In an environment of rising production costs and tighter margins, preventing animal health losses may become a critical factor in maintaining profitability across the U.S. cattle industry.
Comparison Table: Anaplasmosis vs. Theileriosis (Ikeda)
| Category | Anaplasmosis | Theileriosis (Ikeda) |
|---|---|---|
| Cause | Bacterium: Anaplasma marginale | Protozoan: Theileria orientalis (Ikeda genotype) |
| Cells Infected | Red blood cells | White blood cells ? red blood cells (tick transmission); red blood cells only (mechanical transmission) |
| Primary Vector | Native ticks (American dog tick, Rocky Mountain wood tick) | Asian longhorned tick |
| Age Affected | Mostly cattle older than 2 years | Calves and adults |
| Distinctive Signs | Aggression in severe cases, marked spleen enlargement | Ventral edema, moderate spleen enlargement |
| Mortality | Up to 50% of clinically affected adults | Typically 1-5% of the herd; higher in naïve herds |
| Treatment | Oxytetracycline; chlortetracycline for control | No approved U.S. treatment; supportive care only |
| U.S. Vaccine Status | Experimental vaccine available in some states | No approved vaccine currently available |
| U.S. History | Recognized since 1893 and now widespread | First confirmed in 2018 after a 2017 Virginia outbreak |
| Best Diagnostic Test | cELISA for carriers; PCR for acute infection | PCR, including duplex PCR panels |
| Human Health Risk | None | None |

